Esperion Therapeutics
ESPR
ESPR
121 hedge funds and large institutions have $392M invested in Esperion Therapeutics in 2015 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
54% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 54
72% less capital invested
Capital invested by funds: $1.38B → $392M (-$991M)
Holders
121
Holding in Top 10
2
Calls
$13.8M
Puts
$12.1M
Top Buyers
| 1 | +$21.4M | |
| 2 | +$12.4M | |
| 3 | +$10.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.71M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.64M |
Top Sellers
| 1 | -$114M | |
| 2 | -$64.7M | |
| 3 | -$22.4M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$19.1M |
| 5 |
SAM
Senzar Asset Management
New York
|
-$12.6M |